Quantcast

Latest Prostate Stories

2014-01-30 08:31:31

Multiple Studies of Decipher Prostate Cancer Classifier Presented at 2014 ASCO Genitourinary Symposium SAN DIEGO, Jan. 30, 2014 /PRNewswire/ -- GenomeDx Biosciences today announced new data demonstrating that its Decipher® Prostate Cancer Classifier, a genomic test capable of predicting the probability of developing metastatic prostate cancer, outperformed existing clinical risk factors for predicting biochemical failure and distant metastasis following radiation therapy. In addition,...

2014-01-29 12:27:03

NICE Interventional Procedure Guidance recommends use of prostatic urethral lift implants under "normal arrangements", the least restrictive classification PLEASANTON, Calif., Jan. 29, 2014 /PRNewswire/ -- NeoTract, Inc., today announced that the UK's National Institute for Health and Clinical Excellence (NICE) has issued an Interventional Procedure Guidance (IPG) approving the UroLift prostatic urethral lift implant for use by UK doctors. The NICE guidance was made following...

2014-01-24 13:33:49

No meaningful decline in emotional quality of life 2 years after therapy, reports the Journal of Urology A new study published in the Journal of Urology® reports that prostate cancer patients treated with androgen deprivation therapy (ADT) experienced changes in mental and emotional well-being during treatment, although there was no meaningful decline in emotional quality of life two years after treatment. Investigators at the University of California-San Francisco recommend counseling...

2014-01-20 10:32:20

Men who walked at a fast pace prior to a prostate cancer diagnosis had more regularly shaped blood vessels in their prostate tumors compared with men who walked slowly, providing a potential explanation for why exercise is linked to improved outcomes for men with prostate cancer, according to results presented here at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Men who engage in higher levels of physical activity have been...

Melatonin May Play A Role In Reducing Risk Of Prostate Cancer
2014-01-20 03:56:23

American Association for Cancer Research Higher levels of melatonin, a hormone involved in the sleep-wake cycle, may suggest decreased risk for developing advanced prostate cancer, according to results presented in San Diego at the AACR-Prostate Cancer Foundation Conference on Advances in Prostate Cancer Research, held Jan. 18-21. Melatonin is a hormone that is produced exclusively at night in the dark and is an important output of the circadian rhythm, or the body's inherent 24-hour...

2014-01-10 08:23:58

Nomogram aims to enable informed decision-making and personalized treatment SEATTLE, Jan. 10, 2014 /PRNewswire/ -- Studies have found that prostate cancer is overdiagnosed in up to 42 percent of cases, prompting men to receive unnecessary treatment that can cause devastating side effects, including impotence and incontinence. Now, researchers at Fred Hutchinson Cancer Research Center and the University of Washington have developed a personalized tool that can predict the likelihood...

2014-01-09 12:27:22

WASHINGTON, Jan. 9, 2014 /PRNewswire-USNewswire/ -- Prostate cancer continues to be the most common cancer in men, accounting for about 1 in 4 new cases, according to data recently published in CA: A Cancer Journal for Clinicians. The estimated number of new cases and estimated deaths from prostate cancer both decreased slightly for 2014, by 3 percent and 1 percent, respectively. (Logo: http://photos.prnewswire.com/prnh/20130129/DC50244LOGO) "Every week I talk with at least one family man in...

2014-01-07 10:42:10

Using a nomogram that incorporates age, Gleason score, and prostate-specific antigen (PSA) level at diagnosis, individual risks that a screen-detected prostate cancer has been overdiagnosed can be estimated, according to a new study published January 6 in the Journal of the National Cancer Institute. The authors used a standard definition of overdiagnosis to refer to a cancer that would not have become symptomatic or clinically identifiable if it had not been detected by screening....

2014-01-07 08:31:48

LOS ANGELES, Jan. 7, 2014 /PRNewswire/ -- Interim results from a clinical trial of Prostate Health Cocktail (PHC®) show promise that OncoNatural's over-the-counter dietary supplement may soon become a widely recognized adjunct treatment for prostate disease. Prostate specific antigen, or PSA, was effectively stabilized in more than 83% of study participants. Equally important, PHC demonstrated far less impact on quality of life and physical wellbeing metrics when compared with traditional...


Latest Prostate Reference Libraries

Prostate
2013-03-04 15:21:55

The male prostate gland acts as an exocrine gland in the male reproductive system. It is a firm, partly muscular, chestnut sized gland near the neck of the urethra in males. Formation and Orientation The prostate is usually formed within the ninth week of the embryonic stage in reproductive development. The prostate can be separated into either “lobes” or “zones”. When looking at a prostate divided into zones, there are four distinct regions. The first zone is the Peripheral...

More Articles (1 articles) »
Word of the Day
barratry
  • The offense of persistently instigating lawsuits, typically groundless ones.
  • An unlawful breach of duty on the part of a ship's master or crew resulting in injury to the ship's owner.
  • Sale or purchase of positions in church or state.
This word ultimately comes from the Old French word 'barater,' to cheat.
Related